Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
The Iowa Orthopaedic Journal|August 11, 2005
ACL tears in collegiate wrestlers: report of six cases in one seasonAndrew J Lightfoot, Todd McKinley, Matthew Doyle, et al.Current Opinion in Urology|July 14, 2010
Inflatable penile prostheses: an updateAndrew J Lightfoot, Henry M Rosevear, Karl J KrederThescientificworldjournal|March 15, 2011
Recognition and treatment of BCG failure in bladder cancerAndrew J Lightfoot, Henry M Rosevear, Michael A O'DonnellCurrent Opinion in Investigational Drugs (London, England : 2000)|May 25, 2010
Conatumumab, a fully human mAb against death receptor 5 for the treatment of cancerHenry M Rosevear, Andrew J Lightfoot, Thomas S GriffithProstate International|July 10, 2015
Can robot-assisted radical prostatectomy be taught to chief residents and fellows without affecting operative outcomes?Ziho Lee, Andrew J Lightfoot, Phillip Mucksavage, et al.The Journal of Urology|April 19, 2011
Current and future need for academic urologists in the United StatesAndrew J Lightfoot, Henry M Rosevear, William D Steers, et al.Cancer Metastasis Reviews|December 8, 2009
The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladderHenry M Rosevear, Andrew J Lightfoot, Michael A O'Donnell, et al.The Journal of Urology|September 18, 2010
Safety and efficacy of intravesical bacillus Calmette-Guérin plus interferon α-2b therapy for nonmuscle invasive bladder cancer in patients with prosthetic devicesHenry M Rosevear, Andrew J Lightfoot, Kenneth G Nepple, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|July 6, 2012
Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancerAndrew J Lightfoot, Henry M Rosevear, Kenneth G Nepple, et al.The Journal of Urology|November 16, 2010
Usefulness of the Spanish Urological Club for Oncological Treatment scoring model to predict nonmuscle invasive bladder cancer recurrence in patients treated with intravesical bacillus Calmette-Guérin plus interferon-αHenry M Rosevear, Andrew J Lightfoot, Kenneth G Nepple, et al.Pageof 2